Skip to main content

About
Portfolio
Team
Our Impact
News
Pitch for Investment
Founders' Webinar

About
Portfolio
Team
Our Impact
News
Pitch for Investment
Founders' Webinar

Laverock Therapeutics

Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

https://www.laverocktx.com/

Associated Team Members

Oliver Sexton

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, t/a Midven, c/o WeWork, 55 Colmore Row, Birmingham, B3 2AA

Partners
ESG Commitment
Contact
FAQ
Privacy Policy
Terms & Conditions

Site by Digital Glue

Stay updated!

Email

Δ

Managed by

This website uses cookies

We inform you that this site uses own, technical and third parties cookies to make sure our web page is user-friendly and to guarantee a high functionality of the webpage. By continuing to browse this website, you declare to accept the use of cookies.